AChEI is suggested to stop and/or decrease the action of the cholinesterase enzyme in the synaptic cleft of cholinergic cells responsible for the catalytic action of the neurotransmitter ACh hydrolysis in patients with AD [33]. Here, BCHE is linked to Alzheimer disease.